Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real-world data from a diabetes out-patient clinic.

Katrine Bagge Hansen Mathilde Svendstrup Asger LundFilip K KnopTina Vilsbøll Henrik Vestergaard

Published in: Diabetic medicine : a journal of the British Diabetic Association (2021)

We observed effects of semaglutide once weekly on HbA1c and body weight comparable with the effects observed in clinical studies with fewer persons in our cohort receiving maximum dose of semaglutide.

Keyphrases

body weight
type diabetes
cardiovascular disease
primary care
case report
electronic health record
glycemic control
metabolic syndrome
data analysis
replacement therapy
artificial intelligence